A correct molecular diagnosis is of utmost importance, since subjects with HNF1A-MODY are usually very sensitive to oral treatment with sulphonylurea derivatives (SU) such as gliclazide, which can provide excellent diabetes control for decades (7). This evidence concerns the gene HNF1A and diabetes mellitus.